Cardiometabolic Risk Factors in Adolescents with Polycystic Ovary Syndrome

Title:Cardiometabolic Risk Factors in Adolescents with Polycystic Ovary Syndrome

Volume: 27 Issue: 36

Author(s): Anastasia Vatopoulou*, Maria-Eleni Dionelli, Alexis Papanikolaou and Sonia Grover

Affiliation:

• Department of Pediatric and Adolescent Gynecology, The Royal Children’s Hospital, Melbourne,Australia

Keywords: Polycystic ovary syndrome, adolescence, obesity, type 2 diabetes mellitus, hyperandrogenemia, anovulation.

Abstract: It is well-established that adults with polycystic ovary syndrome (PCOS) have an increased prevalence of several cardiometabolic risk factors, including obesity, insulin resistance, type 2 diabetes mellitus, and dyslipidemia. Accumulating data suggest that these risk factors are already present in adolescence in patients with PCOS. This has major implications for the management of this population since the timely identification of these risk factors is essential for preventing cardiovascular disease in adulthood. The present review summarizes the existing evidence regarding the prevalence of traditional and non-traditional cardiometabolic risk factors in adolescents with PCOS.

Cite this article as:

Vatopoulou Anastasia *, Dionelli Maria-Eleni , Papanikolaou Alexis and Grover Sonia , Cardiometabolic Risk Factors in Adolescents with Polycystic Ovary Syndrome, Current Pharmaceutical Design 2021; 27(36) . https://dx.doi.org/10.2174/1381612826666201127123357